[1] Logunov DY, Ilyinskaya GV, Cherenova LV, et al.Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avain adenovirus CELO-p53[J]. Gene Therapy, 2004, 11:79-84. [2] Shashkova EV, Cherenova LV, Kazansky DB, et al.Avain adenovirus vector CELO-TK displays anticancer activity in human cancer cells and suppresses established murine melanoma tumors[J]. Cancer Gene Therapy, 2005, 12:617-626. [3] Francois A, Chevalier C, Delmas B, et al.Avain adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens[J]. Vaccine, 2004, 22:2351-2360. [4] Le Goff F, Méderlé-Mangeot I, Jestin A, et al.Deletion of open reading frame 9, 10 and 11 from the avain adenovirus CELO genome: effect on biodistribution and humoral responses[J]. J General Virol, 2005, 86:2019-2027. [5] Rauw F, Lambrecht B, Francois A, et al.Kinetic and biologic properties of recombinant ChIFN-gamma expressed via CELO-virus vector[J]. J Interferon Cytokine Res, 2007, 27:111-118. [6] 何秀苗. 禽腺病毒载体的构建及其生物学特性的研究[D]. 扬州: 扬州大学兽医学院, 2004. [7] 王凤雪. CELO禽腺病毒载体的构建及fiber 1部分片段的原核表达[D]. 北京: 中国农业科学院, 2005. [8] Tutykhina IL, Bezborodova OA, Shmarov MM, et al.Production of recombinant human lactoferrin in the allantoic fluid of embryonated chick eggs and its characteristics[J]. Protein Expr Purif, 2009, 65:100-107. [9] Michou AI, Lehrmann H, Saltik M, et al.Mutational analysis of the avian adenovirus CELO, which provides a basis for delivery vectors[J]. J Virol, 1999, 73(2):1399-1410. [10] Francois A, Eterradossi N, Delmas B, et al.Construction of avian adenovirus CELO recombinants in cosmids[J]. J Virol, 2001, 75(11):5288-5301. [11] Cherenova LV, Logunov DY, Shashkova EV, et al.Recombinant avian adenovirus CELO expressing the human interleukin-2: characterization in vitro, in ovo and in vivo[J]. Virus Res, 2004, 100:257-261. |